Wuhan RS Pharmaceuticals Co., Ltd., founded in 2009, is one of the core pharmaceutical production bases under QR Group, specializing in the research and development (R&D), production, and global supply of Active Pharmaceutical Ingredients (APIs). Located in Gedian Economic & Technological Development Zone, Hubei Province, the company covers an area of 248,000 m² (372 mu) and operates as a modern API manufacturer compliant with current Good Manufacturing Practice (cGMP) standards.
Backed by profound cross-field technological accumulation and mature industrialization expertise, we have developed a comprehensive and high-quality product portfolio. Our API offerings cover premium-grade varieties for gastrointestinal health, hepatoprotection, hypertension management, antifungal therapy, anti-infective treatments, and bio-fermentation applications. Our core pharmaceutical excipient is Betadex Sulfobutyl Ether Sodium, specifically tailored for premium pharmaceutical formulations. Additionally, our functional additives include ademetionine, glutathione, and sodium hyaluronate with multiple molecular weight specifications. Under rigorous full-process compliance management and control, all core products hold GMP certifications, with multiple varieties already in stable commercial mass production. We provide customized manufacturing solutions, international regulatory compliance registration, and other value-added supporting services, consistently delivering high-quality pharmaceutical raw materials to customers across the globe.
Over the next 3-5 years, we will launch 20-24 new API projects. While ensuring stable raw material supply for the Group’s pharmaceutical formulation business, we will accelerate the layout of global regulatory compliance, striving to become a trusted worldwide partner in the API industry.
